Our latest insights

The Government’s payday superannuation reforms have now passed Parliament without amendment and received Royal Assent. From 1 July 2026, employers must pay superannuation guarantee (SG) contributions on payday, with funds reaching employees’ accounts within 7 business days.

TRACTION For Young People is a not-for-profit organisation striving to make a real difference to young Australians aged between 12-15 who may be at risk of disengaging from school. In this episode of The Remarkables, we chat with Sandy Murdoch, Founder of TRACTION.

Grant Thornton is a leading specialist in AML/CTF risk management and can assist businesses by providing tailored AML/CTF risk management and compliance services

In the mid-sized business space, the conversation around carbon reporting has shifted rapidly from a compliance ‘tick box’ to a genuine commercial lever. While the regulatory landscape is certainly a catalyst, what’s most striking is how mid-sized businesses are engaging with these requirements, not just to meet obligations, but to unlock value. There’s been a shift from compliance to commercial opportunity.

In June this year, APRA published its eight proposed changes to its governance prudential standards. We have summarised APRA’s updated/clarified position and provided guidance on some steps that boards should be doing to prepare for the revised standards.

Unlock ATT accreditation to boost trade compliance, speed, and global market access.

ASIC Commissioner Alan Kirkland outlines key regulatory priorities in the credit sector, focusing on responsible lending, dispute resolution, and protecting vulnerable consumers from misconduct.

Currently, the higher education section is experiencing an evolving risk landscape. As the sector faces mounting pressures – from staff wellbeing to cyber threats – resilience is no longer optional. So how can leaders prepare for the next wave of challenges?

The ATO has published its Public Country-by-Country (CbC) reporting implementation guide, effective for reporting periods starting on or after 1 July 2024.

Built on world-class research and clinical trials, Australia’s biotech industry is increasingly shifting towards commercialisation, global expansion, and long-term growth.

The 2025 Family Business Report explored the mindset of Australian family business leaders as they navigate an increasingly complex and uncertain landscape. While the top challenges varied between incumbent leaders and the rising generation – ranging from staffing and cashflow to succession planning – there was notable alignment with the broader threats identified in the survey.

As this year’s series kicks off in late 2025, continuing through to June 2026, we will bring you virtual on-demand webinars featuring guest speakers, legal and industry experts, and Grant Thornton specialists sharing insights and expectations for the year ahead.